Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18058098 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)
Condition: Neoplasms
Intervention: Drug: Farnesyl Protein Transferase Inhibitor

Indicates status has not been verified in more than two years